ARCUTIS BIOTHERAPEUTIC
10.15
20-September-24 15:59:59
15 minutes delayed
Stocks
+0.01
+0.10%
Today's range
9.78 - 10.31
ISIN
N/A
Source
NASDAQ
-
12 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
05 Sep 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Publishes Annual Environmental, Social, and Governance (ESG) Report
31 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
29 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Appoints Interim Chief Financial Officer (CFO)
18 Aug 2023 16:30:00 By Nasdaq GlobeNewswire
-
10 Aug 2023 08:16:31 By Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update
08 Aug 2023 16:02:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 16:00:00 By Nasdaq GlobeNewswire
-
17 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
06 Jun 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jun 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Leadership Transition
24 May 2023 17:00:03 By Nasdaq GlobeNewswire
-
Arcutis Announces First Quarter 2023 Financial Results and Provides Business Update
09 May 2023 16:02:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 May 2023 16:00:00 By Nasdaq GlobeNewswire
-
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
28 Apr 2023 16:01:57 By Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter Financial Results
25 Apr 2023 16:00:00 By Nasdaq GlobeNewswire
-
18 Apr 2023 08:00:01 By Nasdaq GlobeNewswire